Developer docs
API playgroundTry for free, no card

Search company profiles

Sanolla

Full company profile

uuid0000iwl

Namestring
Sanolla
Legal namestring
Sanolla Ltd.
Websiteurl
sanolla.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Sanolla is an Israeli medical device company founded in 2016 that develops infrasound-based AI diagnostic stethoscopes for healthcare providers and patients. The company is headquartered in Nesher, Israel with a US commercial office in Houston, Texas, and operates with 11-50 employees. Its platform centers on its patented BOOST™ infrasound technology, which captures low-frequency body sounds below the 30Hz threshold of human hearing and shifts them into the audible range, combined with on-device Edge AI algorithms trained on a proprietary database of over 100,000 auscultation recordings from clinical institutions across the EU and US.

The company's commercial product portfolio comprises two primary devices. VoqX is an FDA 510(k)-cleared smart stethoscope that performs full-spectrum auscultation for cardiac and pulmonary assessments, providing real-time AI classification for conditions including COPD, pneumonia, asthma, and cardiac morbidities in approximately 8 seconds per reading, with 40x sound amplification, active noise cancellation, Bluetooth connectivity, and a built-in display for waveforms and spectrographs. PyXy is a home-based monitoring device for chronic patients with congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD) that captures infrasound alongside ECG and SpO2 data for continuous remote monitoring and early deterioration detection. VoqX received FDA 510(k) clearance in April 2022 as the first stethoscope cleared to detect infrasound and audible information, and Sanolla holds ISO 13485 certification, Israeli Health Ministry approval, and HIPAA/GDPR-compliant data handling.

Sanolla generates revenue primarily through one-time hardware sales of VoqX at an introductory price of $499 (standard pricing $750) directly to physicians, nurses, paramedics, and healthcare providers via its own e-commerce storefront (sanolla.com/shop/), with an optional $32 extended warranty add-on and a 30-day money-back guarantee. The company also operates an enterprise inside-sales motion via a 'Get Your Special Quote' form for practice and bulk orders handled by product specialists. Distribution is anchored in the US with international shipping expanding to select countries. Sales were launched to the mass market via the Houston office in September 2025. Cumulative disclosed funding totals approximately $12.36M from sources including NextLeap Ventures ($5M seed, March 2016), the Israel Innovation Authority (~$1.9M in grants across 2017-2020), and the EU Horizon 2020 program (~$5.96M in October 2020 for COVID-19 related acoustic diagnostics).

Short descriptiontext

Sanolla develops FDA-cleared AI-powered smart stethoscopes (VoqX) using patented infrasound technology to capture sub-30Hz body sounds, serving physicians, nurses, paramedics, and chronic disease patients with real-time on-device cardiac and pulmonary diagnostics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCaesarea, Israel
HQ citystring
Caesarea
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
smart stethoscope, infrasound auscultation, AI medical diagnostics, cardiopulmonary monitoring, digital health devices
Industry3 codes
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLALAGAF
Pulmonology & Sleep Medicine Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Smart Medical Diagnostic Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1VoqX Smart Stethoscope Sales
TypeHardware Sales
Description

One-time hardware sales of the VoqX FDA-cleared smart stethoscope. The device is sold directly to physicians, nurses, paramedics, and healthcare providers through the Sanolla website and sales team. Pricing is tiered with introductory pricing at $499 and standard pricing at $750.

sanolla.com
2Extended Warranty
TypeOne Time License
Description

Sanolla offers extended warranty coverage purchasable at checkout for $32, extending the standard two-year warranty by one additional year to a total of three years.

sanolla.com
3Home Monitoring Device (PyXy)
TypeHardware Sales
Description

The PyXy home-based monitoring device captures full-range body sounds including infrasound alongside ECG and SpO2 levels for chronic patients with CHF and COPD. This product line targets home monitoring for chronic disease management.

sanolla.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Others
Pricing details3 tiers
1VoqX introductory pricing - limited time offer
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Limited-time introductory price of $499 (reduced from $750 standard price)

sanolla.com
2VoqX standard pricing
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Standard price of $750 per device

sanolla.com
3Extended warranty - one additional year
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$32 for one additional year of warranty coverage beyond the standard two-year warranty

sanolla.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1VoqX
Description

AI-powered digital stethoscope capable of full-spectrum auscultation including infrasound detection, FDA-cleared for cardiac and pulmonary diagnostics.

sanolla.com
+2 more records
Core offering1 text field

Sanolla develops and sells AI-powered smart stethoscopes and home monitoring devices that capture full-spectrum body sounds including infrasound (below 30Hz) using its patented BOOST™ technology. The flagship VoqX is an FDA-cleared digital stethoscope with on-device Edge AI analysis for cardiac and pulmonary diagnostics, while the PyXy is a home monitoring device for chronic patients with CHF and COPD.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Pneumonia detection rates of 85-95% compared to 50-60% with traditional stethoscopes
+2 more records
Product overview1 text field

Sanolla offers two AI-powered diagnostic devices: VoqX, an FDA-cleared smart stethoscope with infrasound auscultation and real-time AI analysis for heart and lung conditions targeting physicians, nurses, paramedics and home care providers; and PyXy, a home monitoring device for chronic patients (CHF/COPD) that captures infrasound, ECG and SpO₂ for continuous remote monitoring and early deterioration detection.

Product and service3 records
1VoqX Smart Stethoscope
CategorySmart Stethoscope / Medical Diagnostic Device
Description

FDA-cleared AI-powered smart stethoscope capable of full-spectrum auscultation including infrasound detection (below 30Hz). Features real-time on-device Edge AI analysis for heart and lung conditions, built-in display for waveforms and spectrographs, 40x sound amplification, active noise cancellation, Bluetooth connectivity, and dual heart/lung modes. Sold to physicians, nurses, paramedics, and healthcare providers.

2VoqX Shop (Direct-to-Consumer Sales Channel)
CategorySmart Stethoscope Sales Channel
Description

Direct-to-consumer sales page offering the VoqX stethoscope with introductory pricing at $499 (standard $750), carrying case, charging cable, instructions, free US shipping, and 30-day money-back guarantee for purchase by individual clinicians and consumers.

3PyXy Home Monitoring Device
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on Sanolla's website. Nature of partnership not explicitly detailed in available source material.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on Sanolla's website. Nature of partnership not explicitly detailed in available source material.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a partner on Sanolla's website. Nature of partnership not explicitly detailed in available source material.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Norwegian hospital listed as a partner on Sanolla's website. Nature of partnership not explicitly detailed in available source material.

5Rambam Medical Center
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Israeli hospital listed as a partner on Sanolla's website, likely involved in clinical validation and research.

sanolla.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Israeli hospital (Clalit) listed as a partner on Sanolla's website.

7Carmel Medical Center
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Israeli hospital (Clalit) listed as a partner on Sanolla's website.

sanolla.com
8Galilee Medical Center
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Israeli hospital where Dr. Mordechai Alpern serves as Senior Emergency Physician and provides VoqX testimonials.

sanolla.com
9Emek Medical Center
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Israeli hospital (Clalit) listed as a partner on Sanolla's website.

sanolla.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Israeli hospital listed as a partner on Sanolla's website.

11Barzilai Medical Center
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Israeli hospital listed as a partner on Sanolla's website.

sanolla.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Israeli hospital listed as a partner on Sanolla's website.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Israeli hospital (Clalit) listed as a partner on Sanolla's website.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Israeli hospital listed as a partner on Sanolla's website.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Major Israeli hospital listed as a partner on Sanolla's website.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Eko Health is the leading AI-powered digital stethoscope company (Eko Core, DUO, SENSORA) and the most direct competitor to Sanolla's VoqX. Both firms sell AI-augmented auscultation devices to physicians and health systems and pursue similar pulmonology/cardiology diagnostic use cases.

TypeBroad incumbent
Description

3M Littmann is the dominant incumbent in the stethoscope category and, through the Littmann CORE digital stethoscope (built with Eko), competes in the same AI auscultation space as VoqX. It shares Sanolla's physician customer base and offers overlapping digital auscultation features but as part of a broader medical disposables portfolio.

TypeDirect peer
Description

Thinklabs manufactures digital stethoscopes (One, em) with amplification and digital signal capture aimed at clinicians seeking upgraded auscultation. It overlaps with VoqX on the digital-stethoscope-for-physicians product/market axis.

TypeEmerging player
Description

Sonavi Labs develops AI-enabled digital stethoscopes for respiratory disease detection (notably tuberculosis), pairing acoustic capture with machine-learning classification. It is an emerging peer with technology and use case closely comparable to Sanolla's VoqX but with a narrower indication focus.

TypeEmerging player
Description

HD Medical builds AI-augmented auscultation and stethoscope products (e.g., HD Steth) for cardiac and pulmonary screening. Its product offering and clinical-decision-support positioning closely parallel Sanolla's VoqX for clinicians and point-of-care screening.

TypeBroad incumbent
Description

AliveCor (KardiaMobile/Kardia devices) provides consumer and clinician ECG/EKG monitoring with AI interpretation, targeting similar cardiac diagnostic and remote-monitoring needs as VoqX and PyXy, though its modality is single-lead ECG rather than auscultation.

TypeBroad incumbent
Description

iRhythm's Zio ambulatory cardiac monitor and AI ECG services address continuous cardiac arrhythmia detection for clinicians and patients. Its target indications and remote-monitoring business model closely overlap with PyXy's chronic-patient monitoring use case.

TypeBroad incumbent
Description

Philips offers broad patient monitoring and RPM solutions (telehealth, IntelliVue, remote cardiac/pulmonary programs) targeted at hospitals, IDNs, and chronic disease home monitoring. Its cardiac/pulmonary RPM portfolio overlaps with both VoqX in hospital settings and PyXy in home monitoring.

TypeBroad incumbent
Description

Withings produces connected health devices (BPM Core, Body Cardio, ScanWatch with ECG) for consumers and clinicians. Its cardio-monitoring devices overlap with VoqX and PyXy across consumer/clinical ECG, BPM, and home monitoring applications.

TypeOthers
Description

Caretaker Medical provides wearable, wireless continuous vital-sign monitors capturing blood pressure and heart rate using pulse-deconvolution technology, sold to clinicians for remote patient monitoring. It is an enabling/adjacent peer whose RPM infrastructure and clinician relationships could overlap with PyXy's chronic-monitoring channel.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sanolla

Smart Medical Diagnostic Devicessanolla.com

Sanolla develops FDA-cleared AI-powered smart stethoscopes (VoqX) using patented infrasound technology to capture sub-30Hz body sounds, serving physicians, nurses, paramedics, and chronic disease patients with real-time on-device cardiac and pulmonary diagnostics.

What Sanolla does

Sanolla is an Israeli medical device company founded in 2016 that develops infrasound-based AI diagnostic stethoscopes for healthcare providers and patients. The company is headquartered in Nesher, Israel with a US commercial office in Houston, Texas, and operates with 11-50 employees. Its platform centers on its patented BOOST™ infrasound technology, which captures low-frequency body sounds below the 30Hz threshold of human hearing and shifts them into the audible range, combined with on-device Edge AI algorithms trained on a proprietary database of over 100,000 auscultation recordings from clinical institutions across the EU and US.

The company's commercial product portfolio comprises two primary devices. VoqX is an FDA 510(k)-cleared smart stethoscope that performs full-spectrum auscultation for cardiac and pulmonary assessments, providing real-time AI classification for conditions including COPD, pneumonia, asthma, and cardiac morbidities in approximately 8 seconds per reading, with 40x sound amplification, active noise cancellation, Bluetooth connectivity, and a built-in display for waveforms and spectrographs. PyXy is a home-based monitoring device for chronic patients with congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD) that captures infrasound alongside ECG and SpO2 data for continuous remote monitoring and early deterioration detection. VoqX received FDA 510(k) clearance in April 2022 as the first stethoscope cleared to detect infrasound and audible information, and Sanolla holds ISO 13485 certification, Israeli Health Ministry approval, and HIPAA/GDPR-compliant data handling.

Sanolla generates revenue primarily through one-time hardware sales of VoqX at an introductory price of $499 (standard pricing $750) directly to physicians, nurses, paramedics, and healthcare providers via its own e-commerce storefront (sanolla.com/shop/), with an optional $32 extended warranty add-on and a 30-day money-back guarantee. The company also operates an enterprise inside-sales motion via a 'Get Your Special Quote' form for practice and bulk orders handled by product specialists. Distribution is anchored in the US with international shipping expanding to select countries. Sales were launched to the mass market via the Houston office in September 2025. Cumulative disclosed funding totals approximately $12.36M from sources including NextLeap Ventures ($5M seed, March 2016), the Israel Innovation Authority (~$1.9M in grants across 2017-2020), and the EU Horizon 2020 program (~$5.96M in October 2020 for COVID-19 related acoustic diagnostics).

Sanolla firmographics

Firmographics
Name
Sanolla
Legal name
Sanolla Ltd.
Website
https://sanolla.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Sanolla develops FDA-cleared AI-powered smart stethoscopes (VoqX) using patented infrasound technology to capture sub-30Hz body sounds, serving physicians, nurses, paramedics, and chronic disease patients with real-time on-device cardiac and pulmonary diagnostics.
Ownership category
akta.pro rank

Sanolla industry classification

Industry
Product category
Smart Medical Diagnostic Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLALAGAF
Pulmonology & Sleep Medicine Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • Smart stethoscope
  • Infrasound auscultation
  • AI medical diagnostics
  • Cardiopulmonary monitoring
  • Digital health devices

Where Sanolla is headquartered

Location

Headquarters

HQ city
Caesarea
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

Sanolla business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Others

Revenue model

  1. VoqX Smart Stethoscope Sales: One-time hardware sales of the VoqX FDA-cleared smart stethoscope. The device is sold directly to physicians, nurses, paramedics, and healthcare providers through the Sanolla website and sales team. Pricing is tiered with introductory pricing at $499 and standard pricing at $750.
  2. Extended Warranty: Sanolla offers extended warranty coverage purchasable at checkout for $32, extending the standard two-year warranty by one additional year to a total of three years.
  3. Home Monitoring Device (PyXy): The PyXy home-based monitoring device captures full-range body sounds including infrasound alongside ECG and SpO2 levels for chronic patients with CHF and COPD. This product line targets home monitoring for chronic disease management.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goVoqX introductory pricing - limited time offer
One time/ perpetual licensePay-as-you-goVoqX standard pricing
Unit PricingPay-as-you-goExtended warranty - one additional year

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Sanolla product offering

Product offering

Core offering

Sanolla develops and sells AI-powered smart stethoscopes and home monitoring devices that capture full-spectrum body sounds including infrasound (below 30Hz) using its patented BOOST™ technology. The flagship VoqX is an FDA-cleared digital stethoscope with on-device Edge AI analysis for cardiac and pulmonary diagnostics, while the PyXy is a home monitoring device for chronic patients with CHF and COPD.

Product overview

Sanolla offers two AI-powered diagnostic devices: VoqX, an FDA-cleared smart stethoscope with infrasound auscultation and real-time AI analysis for heart and lung conditions targeting physicians, nurses, paramedics and home care providers; and PyXy, a home monitoring device for chronic patients (CHF/COPD) that captures infrasound, ECG and SpO₂ for continuous remote monitoring and early deterioration detection.

Differentiator

Problem solved

Functional benefit

Brands

  • VoqX: AI-powered digital stethoscope capable of full-spectrum auscultation including infrasound detection, FDA-cleared for cardiac and pulmonary diagnostics.
  • PyXy
  • BOOST

Products and services

  • VoqX Smart Stethoscope FDA-cleared AI-powered smart stethoscope capable of full-spectrum auscultation including infrasound detection (below 30Hz). Features real-time on-device Edge AI analysis for heart and lung conditions, built-in display for waveforms and spectrographs, 40x sound amplification, active noise cancellation, Bluetooth connectivity, and dual heart/lung modes. Sold to physicians, nurses, paramedics, and healthcare providers.
  • VoqX Shop (Direct-to-Consumer Sales Channel) Direct-to-consumer sales page offering the VoqX stethoscope with introductory pricing at $499 (standard $750), carrying case, charging cable, instructions, free US shipping, and 30-day money-back guarantee for purchase by individual clinicians and consumers.
  • PyXy Home Monitoring Device

Quantifiable outcome

  • Pneumonia detection rates of 85-95% compared to 50-60% with traditional stethoscopes
  • +2 more outcomes

Companies that use Sanolla

Customer profile

Named customers6 records

Segments7 records

Ideal customer profiles4 records

Sanolla technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature10 records

Sanolla partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered minor.

  • RiesterminorStrategic or Co-development PartnerListed as a partner on Sanolla's website. Nature of partnership not explicitly detailed in available source material.
  • NataliminorStrategic or Co-development PartnerListed as a partner on Sanolla's website. Nature of partnership not explicitly detailed in available source material.
  • BeneVitminorStrategic or Co-development PartnerListed as a partner on Sanolla's website. Nature of partnership not explicitly detailed in available source material.
  • HelgelandssykehusetminorStrategic or Co-development PartnerNorwegian hospital listed as a partner on Sanolla's website. Nature of partnership not explicitly detailed in available source material.
  • Rambam Medical CenterminorStrategic or Co-development PartnerIsraeli hospital listed as a partner on Sanolla's website, likely involved in clinical validation and research.
  • Rabin Medical CenterminorStrategic or Co-development PartnerIsraeli hospital (Clalit) listed as a partner on Sanolla's website.
  • Carmel Medical CenterminorStrategic or Co-development PartnerIsraeli hospital (Clalit) listed as a partner on Sanolla's website.
  • Galilee Medical CenterminorStrategic or Co-development PartnerIsraeli hospital where Dr. Mordechai Alpern serves as Senior Emergency Physician and provides VoqX testimonials.
  • Emek Medical CenterminorStrategic or Co-development PartnerIsraeli hospital (Clalit) listed as a partner on Sanolla's website.
  • Hillel Yaffe Medical CenterminorStrategic or Co-development PartnerIsraeli hospital listed as a partner on Sanolla's website.
  • Barzilai Medical CenterminorStrategic or Co-development PartnerIsraeli hospital listed as a partner on Sanolla's website.
  • Shamir Medical CenterminorStrategic or Co-development PartnerIsraeli hospital listed as a partner on Sanolla's website.
  • Meir Medical CenterminorStrategic or Co-development PartnerIsraeli hospital (Clalit) listed as a partner on Sanolla's website.
  • Laniado HospitalminorStrategic or Co-development PartnerIsraeli hospital listed as a partner on Sanolla's website.
  • Tel Aviv Sourasky Medical CenterminorStrategic or Co-development PartnerMajor Israeli hospital listed as a partner on Sanolla's website.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Sanolla competitors and assessment

Company assessment

Direct peers

  • Eko Health: Eko Health is the leading AI-powered digital stethoscope company (Eko Core, DUO, SENSORA) and the most direct competitor to Sanolla's VoqX. Both firms sell AI-augmented auscultation devices to physicians and health systems and pursue similar pulmonology/cardiology diagnostic use cases.
  • Thinklabs: Thinklabs manufactures digital stethoscopes (One, em) with amplification and digital signal capture aimed at clinicians seeking upgraded auscultation. It overlaps with VoqX on the digital-stethoscope-for-physicians product/market axis.

Broad incumbents

  • 3M Littmann: 3M Littmann is the dominant incumbent in the stethoscope category and, through the Littmann CORE digital stethoscope (built with Eko), competes in the same AI auscultation space as VoqX. It shares Sanolla's physician customer base and offers overlapping digital auscultation features but as part of a broader medical disposables portfolio.
  • AliveCor: AliveCor (KardiaMobile/Kardia devices) provides consumer and clinician ECG/EKG monitoring with AI interpretation, targeting similar cardiac diagnostic and remote-monitoring needs as VoqX and PyXy, though its modality is single-lead ECG rather than auscultation.
  • iRhythm Technologies: iRhythm's Zio ambulatory cardiac monitor and AI ECG services address continuous cardiac arrhythmia detection for clinicians and patients. Its target indications and remote-monitoring business model closely overlap with PyXy's chronic-patient monitoring use case.
  • Philips Healthcare: Philips offers broad patient monitoring and RPM solutions (telehealth, IntelliVue, remote cardiac/pulmonary programs) targeted at hospitals, IDNs, and chronic disease home monitoring. Its cardiac/pulmonary RPM portfolio overlaps with both VoqX in hospital settings and PyXy in home monitoring.
  • Withings: Withings produces connected health devices (BPM Core, Body Cardio, ScanWatch with ECG) for consumers and clinicians. Its cardio-monitoring devices overlap with VoqX and PyXy across consumer/clinical ECG, BPM, and home monitoring applications.

Emerging players

  • Sonavi Labs: Sonavi Labs develops AI-enabled digital stethoscopes for respiratory disease detection (notably tuberculosis), pairing acoustic capture with machine-learning classification. It is an emerging peer with technology and use case closely comparable to Sanolla's VoqX but with a narrower indication focus.
  • HD Medical: HD Medical builds AI-augmented auscultation and stethoscope products (e.g., HD Steth) for cardiac and pulmonary screening. Its product offering and clinical-decision-support positioning closely parallel Sanolla's VoqX for clinicians and point-of-care screening.

Others

  • Caretaker Medical: Caretaker Medical provides wearable, wireless continuous vital-sign monitors capturing blood pressure and heart rate using pulse-deconvolution technology, sold to clinicians for remote patient monitoring. It is an enabling/adjacent peer whose RPM infrastructure and clinician relationships could overlap with PyXy's chronic-monitoring channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

Sanolla social profiles

Digital presence

Sanolla compliance and trust

Trust signal

Compliance4 records

Sanolla financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sanolla leadership team

Management profile

Number of profiles

Profiles9 records

Sanolla funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sanolla M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sanolla

What does Sanolla do?

Sanolla develops and sells AI-powered smart stethoscopes and home monitoring devices that capture full-spectrum body sounds including infrasound (below 30Hz) using its patented BOOST™ technology. The flagship VoqX is an FDA-cleared digital stethoscope with on-device Edge AI analysis for cardiac and pulmonary diagnostics, while the PyXy is a home monitoring device for chronic patients with CHF and COPD.

Is Sanolla a public or private company?

Sanolla is a private company. It is classified as venture growth investor backed and is currently operating.

When was Sanolla founded?

Sanolla was founded in 2016. It employs 11 to 50 people.

Where is Sanolla based?

Sanolla is headquartered in Caesarea, Israel, in the Middle East region.

How does Sanolla make money?

Three revenue lines are on record. VoqX Smart Stethoscope Sales are the primary driver. The others are extended Warranty and home Monitoring Device (PyXy).

Who are Sanolla's main competitors?

Direct peers on record are Eko Health and Thinklabs. Broad incumbents are 3M Littmann, AliveCor, iRhythm Technologies, Philips Healthcare and Withings. Emerging players are Sonavi Labs and HD Medical. Caretaker Medical is listed as an others.

Does Sanolla have an API?

No public API is recorded for Sanolla.

What industry is Sanolla in?

Sanolla's product category is Smart Medical Diagnostic Devices. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comKey Factors and Emerging Trends Shaping the Digital Auscultation Market LandscapeThe digital auscultation market is projected to reach $1.85 billion by 2030, growing at a compound annual growth rate of 15.7%, driven by technological advancements, telehealth adoption, and AI integration. Sanolla, a US-based digital health firm, introduced the VoqX smart stethoscope in September 2025, an FDA-approved device capable of full-spectrum auscultation including low-frequency infrasound detection with real-time AI analytics. In October 2024, Strados Labs partnered with Trialogics to expand clinical trial usage of its RESP respiratory monitoring technology.PR NewswireSanolla Launches the World's First Smart AI-powered Stethoscope Offering Full-Spectrum AuscultationSanolla, a medical device company specializing in AI-powered diagnostics, has launched the VoqX smart stethoscope — the world's first AI-enabled device capable of full-spectrum auscultation that analyzes both heart and lung sounds, including previously inaudible low-frequency infrasound. The FDA-certified device uses clinically validated AI algorithms trained on tens of thousands of recordings to provide real-time diagnostic insights for detecting cardiopulmonary conditions. The VoqX is now available directly through Sanolla's website at an introductory price of $499 (reduced from the standard $750), positioning the technology for broader adoption among physicians, nurses, paramedics, and home care providers.NoCamelsIsraeli Health Tech Startups Nab Innovation Awards In TaiwanIsraeli health tech startups Sanolla and Rapid Diagnostics (Naor) won the Breakthrough Innovation Award and the Startup Terrace Award at InoVEX 2022, held in Taiwan as part of COMPUTEX TAIPEI. The Startup Terrace Award includes a $40,000 grant and office space at the Innovation Center. The companies participated remotely under the IP²LaunchPad program.BioSpaceIsraeli startup Sanolla receives FDA clearance for the world’s first AI-ready infrasound stethoscopeSanolla received FDA 510(k) clearance for its VoqX stethoscope, the world's first AI-ready infrasound device. The clearance enables clinical use in the US and Israel, with AI algorithms classifying cardiopulmonary diseases. The company plans a Round A funding raise this summer.BioWorldFDA clears AI-infrasound smart stethoscope from SanollaSanolla Ltd. received U.S. FDA 510(k) clearance for its Voqx smart-infrasound stethoscope. The AI-based device is the first stethoscope cleared to detect infrasound and audible information for early assessment of cardiopulmonary conditions.PR NewswireSanolla Wins Horizon 2020 Funding to Fight COVID-19 with Early Detection and Monitoring TechnologySanolla, an Israeli AI-based medical device startup, won €5 million in Horizon 2020 funding to develop early detection and monitoring tools for COVID-19. Its infra-sound device achieved 89.3% accuracy in classifying COVID-19 versus non-COVID-19 subjects, and 90% detection accuracy for pneumonia. The company aims to bring its instant diagnostic tools to market.